CPRX Past Earnings image   This CPRX past earnings page last updated 5/12/2022
CPRX Past Earnings
Data adjusted for CPRX split history

PeriodPast Earnings DateGAAP
Q1 20225/10/20220.120
Q4 20213/16/20220.090
Q3 202111/9/20210.100
Q2 20218/9/20210.110
Q1 20215/10/20210.070
Q4 20203/15/20210.110
Q3 202011/9/20200.130
Q2 20208/10/20200.090
Q1 20205/11/20200.100
Q4 20193/16/20200.070
Q3 201911/12/20190.130
Q2 20198/7/20190.100
Q1 20195/13/2019-0.010
Q4 20183/18/2019-0.14
Q3 201811/7/2018-0.08
Q2 20188/7/2018-0.06
Q1 20185/9/2018-0.06
Q4 20173/14/2018-0.06
Q3 201711/8/2017-0.05
Q2 20178/9/2017-0.05
Q1 20175/10/2017-0.06
Q4 20163/15/2017-0.05
Q3 201611/9/2016-0.05
Q2 20168/9/2016-0.06
Q1 20165/10/2016-0.07
Q4 20153/15/2016-0.07
Q3 201511/9/2015-0.06
Q2 20158/10/2015-0.06
Q1 20155/11/2015-0.06
Q4 20143/16/2015-0.05
Q3 201411/14/2014-0.06
Q2 20148/14/2014-0.05
Q1 20145/16/2014-0.07
Q4 20133/19/2014-0.05
Q3 201311/13/2013-0.13
Q2 20138/15/2013-0.06
Q1 20135/16/2013-0.04
Q4 20124/2/2013-0.140
Q3 201211/15/2012-0.08
Q2 20128/15/2012-0.01
CPRX Past Revenue
PeriodPast Earnings DateGAAP
Q1 20225/10/20220.04B
Q4 20213/16/20220.04B
Q3 202111/9/20210.04B
Q2 20218/9/20210.04B
Q1 20215/10/20210.03B
Q4 20203/15/20210.03B
Q3 202011/9/20200.03B
Q2 20208/10/20200.03B
Q1 20205/11/20200.03B
Q4 20193/16/20200.03B
Q3 201911/12/20190.03B
Q2 20198/7/20190.03B
Q1 20195/13/20190.01B
Q4 20183/18/2019500000
Q3 201811/7/2018NA
Q2 20188/7/2018NA
Q1 20185/9/2018NA
Q4 20173/14/2018NA
Q3 201711/8/2017NA
Q2 20178/9/2017NA
Q1 20175/10/2017NA
Q4 20163/15/2017NA
Q3 201611/9/2016NA
Q2 20168/9/2016NA
Q1 20165/10/2016NA
Q4 20153/15/2016NA
Q3 201511/9/2015NA
Q2 20158/10/2015NA
Q1 20155/11/2015NA
Q4 20143/16/2015NA
Q3 201411/14/2014NA
Q2 20148/14/2014NA
Q1 20145/16/2014NA
Q4 20133/19/2014NA
Q3 201311/13/2013NA
Q2 20138/15/2013NA
Q1 20135/16/2013NA
Q4 20124/2/2013NA
Q3 201211/15/2012NA
Q2 20128/15/2012NA
Quotes delayed 20 minutes

Email EnvelopeFree CPRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Catalyst Pharmaceuticals (CPRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CRBP Historical Earnings
CRBU Historical Earnings
CRDF Historical Earnings
CRIS Historical Earnings
CRL Historical Earnings
CRMD Historical Earnings
CRNX Historical Earnings
CRTX Historical Earnings
CRVL Historical Earnings
CRVS Historical Earnings

CPRX Past Earnings Q&A

What was the best and worst CPRX past earnings results?
For Catalyst Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest CPRX past earnings result in our data set was 0.130/share posted in Q3 2020, while the lowest was in Q4 2018 when CPRX posted -0.14/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2022 when CPRX reported 0.04B in revenue, while the quarter with the lowest revenue in our data set was Q3 2018 at NA of revenue.

  Suggested answer: There are 40 CPRX past earnings results in our data set.

On this page we presented the CPRX past earnings date information for Catalyst Pharmaceuticals. Reviewing that CPRX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2020, when CPRX posted gaap of 0.130/share. Meanwhile the lowest CPRX past earnings result was in Q4 2018, when CPRX posted gaap of -0.14/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2022 when CPRX reported 0.04B in revenue, while the smallest revenue quarter was Q3 2018 when CPRX reported NA in revenue.

Any self directed investor doing their due diligence on CPRX or any other given stock can benefit from researching all of the Catalyst Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Catalyst Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CPRX. Thanks for visiting, and the next time you need to research CPRX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: HTM Videos, Top Ten Hedge Funds Holding OR, SOPH Videos.

 

CPRX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.